Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...

The following is a summary of “Steroid-resistant nephrotic syndrome due to renal-limited thrombotic microangiopathy and ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Using patient kidney biopsies, the team developed a new method to measure glycocalyx thickness, confirming that the layer is ...

Older adults with advanced kidney disease are often motivated to receive a transplant but may face emotional and psychosocial ...

In a significant step towards addressing public health challenges, the Health Department constituted a dedicated task force ...

These are known as disease-modifying treatments and have been licensed for private use. Other medications are under review to see if they could be prescribed to people in the very early stages of ...

Genetically modified pig kidneys begin trials for 50 U.S. kidney failure patients FDA launches clinical trials for organ ...

Kidney disease affects millions of Americans, with Black communities facing disproportionately higher risks due to genetic factors, socioeconomic challenges, ...

The burden is particularly high in urban areas, where the prevalence reaches 15.2 percent compared to just 2.0 percent in ...